Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrimidine SCHEMBL1766108 | 0.84 | TSHR (0.30) | — | |
| Pyrazine SCHEMBL2492066 | 0.79 | ALDH1A1 (0.33) | ALDH1A1 | |
| Ether SCHEMBL9248674 | 0.76 | ALDH1A1 (0.47) | ALDH1A1 | |
| Ether SCHEMBL21406 | 0.76 | ALDH1A1 (0.47) | ALDH1A1 | |
| Ether SCHEMBL9248046 | 0.76 | ALDH1A1 (0.47) | ALDH1A1 | |
| Ether SCHEMBL6 | 0.76 | — | — | |
| Ether SCHEMBL8160191 | 0.76 | ALDH1A1 (0.47) | ALDH1A1 | |
| Benzene SCHEMBL665216 | 0.72 | ALDH1A1 (0.39) | ALDH1A1 | |
| Benzene SCHEMBL9989943 | 0.72 | ALDH1A1 (0.39) | ALDH1A1 | |
| Ether SCHEMBL27546779 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070111027-A1 | Light-emitting organic materials | NATIONAL SCIENCE FOUNDATION | 2007-05-17 | — | — | US | disclosed |
| WO-2007016454-A2 | LIGHT-EMITTING ORGANIC MATERIALS | UNIVERSITY OF ROCHESTER (US) | 2007-02-08 | — | — | WO | disclosed |
| EP-1549645-A1 | 4,6-DIAMINOSUBSTITUTED-2-[OXY OR AMINOXY]-[1,3,5]TRIAZINES AS PROTEIN TYROSINE KINASE INHIBITORS | Johnson & Johnson Pharmaceutical Research & Development, Inc. (US) | 2005-07-06 | — | — | EP | disclosed |
| US-20040110758-A1 | 4,6-Diaminosubstituted-2-[oxy or aminoxy]-[1,3,5]triazines as protein tyrosine kinase inhibitors | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2004-06-10 | — | — | US | disclosed |
| WO-2004031184-A1 | 4,6-DIAMINOSUBSTITUTED-2-[OXY OR AMINOXY]-[1,3,5]TRIAZINES AS PROTEIN TYROSINE KINASE INHIBITORS | JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, INC. (US) | 2004-04-15 | — | — | WO | disclosed |
| US-5322528-A | Reducing agent precursors | TEXACO INC. (US) | 1994-06-21 | — | — | US | disclosed |
| EP-0564233-A1 | Composition of matter for high temperature phenolphthalein-, phenolphthalide-, fluorene-, xanthane-, and anthrone-S-triazines that are soluble in diesel fuel | TEXACO DEVELOPMENT CORPORATION (US) | 1993-10-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110758-A1 | 4,6-Diaminosubstituted-2-[oxy or aminoxy]-[1,3,5]triazines as protein tyrosine kinase inhibitors | TIE1, KDR, FLT1 | ALDH1A1 462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.